Superior Bioavailability. Enhanced Efficacy. Greater Formulation Flexibility.
Trait VitaComplex is a proprietary pharma-grade water-soluble cannabinoid API technology innovated for pharmaceutical development, with a focus on improving cannabinoid bioavailability and supporting enhanced biological performance.
Cannabinoids are naturally lipophilic and pharma-grade water-insoluble, which can create challenges for absorption and systemic delivery. Trait’s molecularly modified cannabinoid technologies are innovated to address these limitations by improving aqueous compatibility and facilitating efficient cannabinoid delivery into biological environments.
Trait’s APIs Deliver:
True Water Solubility
High-purity CBD dissolves fully in aqueous systems for precise dosing, simplified formulations, and expanded administration options.
Superior Bioavailability
Efficient permeation into circulation and cellular membranes for competitive biological benefits.
Enhanced Efficacy
Enhanced bioavailability allows for enhanced efficacy and at lower dose intakes.
The CBD Bioavailability Challenge
Cannabinoids such as CBD are naturally lipophilic and water-insoluble. These properties can create challenges for absorption, systemic exposure, and consistent delivery.
For pharmaceutical developers, water-insolubility can also restrict formulation options and complicate the development of dosage forms designed for predictable cannabinoid delivery.
Trait VitaComplex addresses this challenge at the molecular level through proprietary modification of the cannabinoid structure to improve its interaction with aqueous environments.
The objective is not simply to make CBD water-soluble, but to develop cannabinoid molecules with properties that may support more efficient absorption, improved bioavailability, and enhanced biological performance.
The Challenge of Being Water-Insoluble
Conventional CBD is not soluble in water, which limit its incorporation into aqueous systems and create challenges for pharmaceutical formulation and delivery.
Bioavailability & Systemic Exposure
Improving the cannabinoid’s compatibility with aqueous environments may facilitate absorption and delivery, supporting research into increased systemic exposure and more predictable pharmacokinetic performance.
Potential for Enhanced Efficacy
When more of an active compound becomes available at the site of action, improved bioavailability support enhanced biological effects and the potential for lower dose requirements.
How Trait VitaComplex Works
Trait uses proprietary molecular modification approaches to change the physicochemical properties of cannabinoids and improve their aqueous compatibility. The focus is on the resulting molecule and how its properties influence cannabinoid behavior in biological environments.
Molecular Modification
Trait uses proprietary chemical synthesis approaches to modify cannabinoids at the molecular level and purification processes to create water-soluble molecules for pharmaceutical research and development.
True Water Solubility
The resulting molecule dissolves fully in aqueous systems, unlike conventional CBD. True water solubility supports homogeneous formulations, precise dosing, and greater formulation flexibility.
Improved Delivery Potential
True water solubility facilitates movement of the cannabinoid through aqueous biological environments and supports research into permeation, absorption, and systemic exposure.
Bioavailability & Biological Performance
Trait has been conducting studies to support how its water-soluble cannabinoid molecules behave in biological environments, including their potential effects on absorption, bioavailability, and biological performance.
Aqueous Compatibility & Routes of Administration
True water solubility can expand the formulation and delivery options available to pharmaceutical developers.
Trait VitaComplex is innovated for applications where aqueous compatibility and improved bioavailability are important development considerations.
Oral
Supports tablets, capsules, and oral liquids where absorption, bioavailability, and consistent dosing are important.
Buccal & Sublingual
True water solubility provides opportunities to investigate cannabinoid delivery through the oral mucosa.
Topical & Transdermal
Water-soluble cannabinoid technology supports topical and transdermal development programs investigating localized or systemic delivery.
Other Delivery Routes
Provides opportunities to investigate additional delivery approaches, with suitability depending on the formulation and route.
Permeation & Bioavailability Research
Trait is investigating how its water-soluble cannabinoid molecules interact with biological membranes and aqueous biological environments.
True water solubility facilitates cannabinoid movement through biological environments and provides opportunities to investigate permeation, absorption, systemic exposure, and pharmacokinetic performance.
Trait has conducted studies demonstrating enhanced permeation and transport with certain proprietary cannabinoid molecules and continues to conduct molecule-specific research to characterize the bioavailability and biological performance of Trait VitaComplex.
Potential for Enhanced Efficacy
Bioavailability is an important consideration in pharmaceutical development because the amount of active compound that reaches systemic circulation or a relevant site of action can influence biological performance.
Trait’s water-soluble cannabinoid technologies are innovated to improve cannabinoid availability in biological environments.
Improved bioavailability provides the potential for:
- More efficient cannabinoid delivery
- Enhanced biological effects
- More predictable exposure
- Lower dose requirements
- Greater flexibility in dosage-form development
The relationship between bioavailability, dose, and efficacy is molecule- and indication-specific and requires further development and clinical evaluation.
Pharmaceutical Development Potential
Trait VitaComplex is being innovated as a pharma-grade water-soluble cannabinoid API technology for pharmaceutical R&D, with applications across formulation, delivery, absorption, permeation, systemic exposure, pharmacokinetics, dose optimization, and stability.
Trait works with pharmaceutical and biotechnology companies to explore potential applications through collaborative development, licensing, and strategic partnerships.
Depending on the development program, Trait can support technology development, formulation, scale-up, and commercialization through GMP capabilities.
Research Built on Decades of Cannabinoid Science
Trait’s research spans decades of cannabinoid research, including molecular modification, formulation, delivery, bioavailability, absorption, and stability.
Trait VitaComplex builds on this scientific foundation and Trait’s intellectual property to advance water-soluble cannabinoid technologies. Ongoing research continues to examine the relationship between molecular structure, solubility, permeation, absorption, bioavailability, and biological performance.
Cannabinoid API Applications Across Development Pathways
Trait VitaComplex is positioned to support cannabinoid API development across multiple drug delivery pathways and regulatory routes — from OTC consumer health products to prescription pharmaceutical development.
Oral Applications
Tablets, capsules, softgels, and oral liquid formulations requiring improved CBD bioavailability and consistent cannabinoid dosing per unit. Trait VitaComplex’s water solubility enables direct aqueous dissolution without added chemicals.
Injectable & Inhalation Applications
Water solubility is a critical requirement for injectable and inhalation cannabinoid formulations. Trait VitaComplex is a water-soluble cannabinoid API platform compatible with injection and inhalation delivery systems.
Topical Applications
For topical pharmaceutical applications requiring systemic or targeted delivery through the skin, Trait VitaComplex’s water-soluble cannabinoid API supports improved skin permeation versus conventional oil-soluble CBD.
Frequently Asked Questions
What is Trait VitaComplex and what problem does it solve?
Trait VitaComplex is pharma-grade water-soluble cannabinoid active pharmaceutical ingredients (APIs) developed to address the poor bioavailability of conventional CBD. Market CBD has low and inconsistent oral absorption with significant interpatient variability. Trait VitaComplex is structurally modified at the molecular level to improve bioavailability and membrane permeability.
How can improved bioavailability support efficacy?
Bioavailability describes the amount of an active compound that becomes available in the body. Improving bioavailability may increase the amount of active cannabinoid available to relevant biological sites and may support enhanced biological effects or lower dose requirements.
Actual efficacy and dose requirements depend on the specific molecule, indication, formulation, and clinical data.
How does Trait VitaComplex differ from conventional CBD?
Conventional CBD is naturally lipophilic and water-insoluble. Trait VitaComplex uses proprietary molecular modification approaches to create a water-soluble cannabinoid innovated to improve bioavailability, CBD delivery and biological performance.
What routes of administration is Trait VitaComplex suitable for?
Trait VitaComplex is innovated to support multiple routes of administration including oral, buccal, sublingual, topical, transdermal, and other delivery approaches where efficient systemic uptake and consistent pharmacokinetic performance are required.
Is Trait VitaComplex suitable for pharmaceutical development pathways?
Yes. Trait VitaComplex is a patent-protected technology produced at scale, positioned to support both OTC and prescription drug development pathways. Trait is interested in working with pharmaceutical and biotechnology companies to explore development and commercialization opportunities.
Explore Other Trait Biosciences Innovations
Trait Biosciences develops proprietary water-soluble cannabinoid technologies innovated for different applications across human and pet health and wellness.
Trait Distilled™
Water-soluble CBD ingredient for functional / nutraceutical formulation. No emulsifiers required.
Trait GlycoRenew
Water-soluble CBD technology innovated for topical and cosmeceutical formulation.
Trait Companion
Water-soluble CBD technology innovated for companion animal and veterinary health and wellness applications.
